Latest Blogs

Guest Commentary
Mar 16, 2023
Set Up Your Collaborative Team for Success: A Guideline for Advanced Practice Provider/Physician Team-Based Care in Oncology
Clear expectations are key for effective teamwork. Tammy Triglianos, Dr. Ethan Basch, and Dr. Matthew Milowsky share a guidance document to facilitate excellent collaboration in advanced practice provider/physician teams.
Guest Commentary
Mar 14, 2023
Geriatric Oncology: A Training Opportunity That Has Come of Age
Four geriatric oncology experts answer five questions about the field, including what oncology trainees need to know, how to pursue consolidated training, and why geriatric oncology is a meaningful and rewarding career.
International Perspectives
Mar 14, 2023
I Travel for Global Oncology: The Tale of My Great Journey at the University of Lahore in Pakistan
Dr. Khalid El Bairi was invited to participate in the International Summit of Health Professionals in Pakistan, a country he only knew from the news and nature documentaries. The visit challenged his perceptions and allowed him to make valuable connections.
Anees B. Chagpar, MD, MPH, MBA, MSc, MA, FACS, FRCS, FASCO
Mar 07, 2023
ASCO Multidisciplinary Cancer Management Course in Brazil Offers Practical Framework for Engaging Tumor Boards
I recently visited Porto Alegre, Brazil, for an ASCO Multidisciplinary Cancer Management Course. Reducing the global cancer burden is a formidable goal, but one to which ASCO is incredibly committed.
Subscribe to this column

Clifford A. Hudis, MD, FACP, FASCO

Clifford A. Hudis, MD, FACP, FASCO, is the CEO of ASCO, executive vice chair of Conquer Cancer, the ASCO Foundation, and chair of CancerLinQ. Prior to these roles, he served as chief of the Breast Medicine Service and an attending physician at Memorial Sloan Kettering Cancer Center and as a professor in the Department of Medicine at Weill Cornell Medical College. He is a past president of ASCO. His research interests include all areas of care related to breast cancer, with a focus on the development of novel systemic therapies and prevention interventions related to obesity and inflammation. Follow Dr. Hudis on Twitter @CliffordHudis.

Disclosure.

Feb 28, 2022
2021: Looking Back to Plan Ahead
In 2021, the overall COVID-19 situation remained abnormal, but we continued to make noteworthy and long-planned progress against our goals.
Mar 19, 2021
A Personal Remembrance: Dr. Marc L. Citron
Marc showed our entire community how to be a caring colleague, dedicated clinician, and collaborative researcher. He was also devoted to his community and his family, and, through everything, he was simply nice to everyone!
2 Comments
Feb 01, 2021
2020: A Year of Transformation and Growth for ASCO
I believe that we are emerging from this past year strengthened and positioned to make an even greater impact in the future.
Aug 18, 2020
A Conversation With Dr. Lori J. Pierce on Her Plans to Improve Cancer Care Equity During Her ASCO Presidential Year
ASCO president Dr. Lori J. Pierce and I discuss her background, her presidential theme, and ASCO efforts related to health equity and representation.
Jul 07, 2020
ASCO Special Report: Resuming Cancer Care Delivery During COVID-19
Dr. Piyush Srivastava outlines recommendations from the recently released ASCO Special Report provided for oncology practices as they return to more routine care delivery in the pandemic.
Jun 18, 2020
Ethical Considerations for Allocating Scarce Resources During a Pandemic
ASCO Ethics Committee chair Dr. Jonathan Marron and I discuss two recommendations from a recent paper on allocating scarce health care resources during COVID-19.

Pages